Please use this search facility to search all content found within the website:

85 results:

Detailed statement health insurer

A.S.R. For the specified overview of A.S.R. you need to log in to A.S.R.  Log in with your DigiD on the website and view "declaratieoverzicht". Click "farmacie" and then "eigen…

Update Reimbursement Scheme Adempas®

Update Reimbursement Scheme Adempas® As off May 31st 2023, the reimbursement for Adempas® 0.5 mg and 1.0 mg is now also indicated for the treatment of PAH in pediatric patients aged less than…

Adempas®

PATIENTS CAN ONLY CLAIM THEIR PAID CONTRIBUTION, NOT THEIR EXCESS General information The pharmacist has dispensed Adempas® 0.5 or 1mg to the patient. The health insurer will not…

Plenadren®

General information The pharmacist has dispensed PLENADREN® 5 or 20mg to you. The health insurer will not reimburse the cost of this prescription in full. The manufacturer of this medicine has…

Signifor®

General information The pharmacist has dispensed Signifor® 20 mg to the patient. The health insurer will not reimburse the cost of this prescription in full. The producer of this medicine has…

Elvanse®

General information The pharmacist has dispensed ELVANSE® 20, 30, 40, 50, 60 or 70mg to the patient. The health insurer will not reimburse the cost of this prescription in full. The…

Intuniv®

Check your medicine expenses Quickly check the maximum contribution you have to pay for your medicine Check Medicine Expenses General information The pharmacist has dispensed Intuniv® 1,…

Overview Medicines

TBR Nederland provides the following Reimbursement Schemes for the medicines below. No reimbursement is determined yet for these medicines, as a result of which you have to pay a…

Jardiance® - Chronic Kidney Disease

General information You have given Jardiance® 10 mg to a patient or you have obtained this medicine from the pharmacy. The health care insurer does not yet reimburse Jardiance® for the treatment of…

Jardiance® - HF

General information From April 1, 2023, the use of Jardiance® (empagliflozin) in patients with chronic heart failure regardless of ejection fraction (HFrEF, HFmrEF and HFpEF) is regularly reimbursed…

You are currently offline. Some pages or content may fail to load.